We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-0.52%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$14.2B
AUM Growth
-$8.36B
Cap. Flow
-$7.74B
Cap. Flow %
-54.45%
Top 10 Hldgs %
26.45%
Holding
2,855
New
868
Increased
575
Reduced
650
Closed
706

Sector Composition

Rank Sector Weight
1 Technology 13.22%
2 Industrials 12.12%
3 Financials 10.01%
4 Consumer Discretionary 7%
5 Healthcare 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GENI icon
1926
Genius Sports
GENI
$1.85B
$68.1K ﹤0.01%
15,373
-42,417
-73% -$302K
VENU
1927
Venu Holding Corp
VENU
$117M
$67.3K ﹤0.01%
+20,318
New +$117K
PAII.WS
1928
Pyrophyte Acquisition Corp II Warrants
PAII.WS
$66K ﹤0.01%
200,000
-16,601
-8% -$6.23K
TOI icon
1929
The Oncology Institute
TOI
$486M
$65.2K ﹤0.01%
+21,234
New +$65.1K
SPRU icon
1930
Spruce Power Holding Corp
SPRU
$35.8M
$65K ﹤0.01%
+15,863
New +$73.5K
KCHVR
1931
Kochav Defense Acquisition Corp Right
KCHVR
$64.8K ﹤0.01%
281,799
-3,201
-1% -$816
LEGT.WS
1932
DELISTED
Legato Merger Corp III Warrants
LEGT.WS
$64.7K ﹤0.01%
129,425
+63,724
+97% +$32.2K
LUNG icon
1933
Pulmonx
LUNG
$68.8M
$64.2K ﹤0.01%
49,788
-70,905
-59% -$117K
JRVR icon
1934
James River Group Holdings
JRVR
$208M
$64K ﹤0.01%
10,157
-11,744
-54% -$77.2K
SVRA icon
1935
Savara
SVRA
$1.12B
$63.1K ﹤0.01%
+11,549
New +$64.3K
CCCC icon
1936
C4 Therapeutics
CCCC
$385M
$63K ﹤0.01%
+23,944
New +$56.4K
AIV
1937
Aimco
AIV
$387M
$62.3K ﹤0.01%
15,307
-1,478,225
-99% -$7.74M
TDWDR
1938
Tailwind 2.0 Acquisition Corp Rights
TDWDR
$61.7K ﹤0.01%
+397,705
New +$68.8K
ENTX icon
1939
Entera Bio
ENTX
$147M
$61.3K ﹤0.01%
55,223
-541,362
-91% -$760K
XGN icon
1940
Exagen
XGN
$109M
$61K ﹤0.01%
20,333
+6,912
+52% +$26.7K
NB
1941
NioCorp Developments
NB
$619M
$60.1K ﹤0.01%
13,481
-95,149
-88% -$546K
HNST icon
1942
The Honest Company
HNST
$402M
$59K ﹤0.01%
+20,071
New +$51.6K
PROK icon
1943
ProKidney
PROK
$316M
$58.8K ﹤0.01%
+32,845
New +$69.7K
PALI icon
1944
Palisade Bio
PALI
$330M
$58K ﹤0.01%
33,146
+21,915
+195% +$39.9K
CSAN icon
1945
Cosan
CSAN
$3.18B
$56.7K ﹤0.01%
13,754
-19,783
-59% -$86.5K
DPRO
1946
Draganfly
DPRO
$153M
$55.2K ﹤0.01%
+11,239
New +$83.3K
TBLA icon
1947
Taboola.com
TBLA
$1.37B
$54.9K ﹤0.01%
17,704
-91,743
-84% -$328K
GTENW
1948
Gores Holdings X Warrants
GTENW
$54.6K ﹤0.01%
97,503
ASTL icon
1949
Algoma Steel
ASTL
$406M
$54.5K ﹤0.01%
+13,188
New +$57.2K
IGACR
1950
Invest Green Acquisition Corp Rights
IGACR
$54.4K ﹤0.01%
+320,000
New +$60K

Similar funds

Schonfeld Strategic Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Schonfeld Strategic Advisors held 2,855 positions worth $14.2B, down 37% from $22.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Schonfeld Strategic Advisors withdrew a net $7.74B in Q1 2026, closing 706 positions and reducing 650 holdings. Its most notable exit was First Solar, an estimated $61.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

Against the trend, Schonfeld Strategic Advisors opened a new position in T-Mobile US worth $75.9M.

  • Schonfeld Strategic Advisors's largest Q1 2026 buy was T-Mobile US: 361,548 shares worth $75.9M.
  • Schonfeld Strategic Advisors added most to Micron Technology in Q1 2026, an estimated $155M increase.
  • Schonfeld Strategic Advisors's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $3.6B.
  • Schonfeld Strategic Advisors fully exited First Solar in Q1 2026, selling an estimated $61.5M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 26% of its $14.2B portfolio in Q1 2026.
  • Schonfeld Strategic Advisors opened 868 new positions and closed 706 in Q1 2026.
  • Schonfeld Strategic Advisors's portfolio value fell 37% quarter-over-quarter to $14.2B.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.